Dihydropyrans
FULL PAPER
1431 cmÀ1
;
1H NMR (500 MHz, CDCl3): d=7.32(d, J=8.1 Hz, 2H), 6.85
J=5.5, 5.5 Hz, 1H), 4.07–4.11 (m, 1H), 3.96 (dq, J=9.6, 7.1 Hz, 1H),
3.50–3.66 (m, 2H), 2.42 (d, J=5.7 Hz, 1H), 2.18–2.23 (m, 2H), 1.80–1.90
(m, 1H), 1.50–1.60 (m, 1H), 1.22–1.38 (m, 4H), 0.96 (d, J=7.8 Hz, 3H),
0.93 ppm (d, J=7.8 Hz, 3H); 13C NMR (125 MHz, CDCl3): d=126.6,
124.7, 98.4, 77.7, 71.4, 64.2, 41.9, 31.1, 24.4, 23.6, 21.8, 15.1 ppm; HRMS
(ESI): m/z: calcd for C12H22O3Na: 237.1461; found: 237.1461.
(d, J=8.1 Hz, 2H), 5.72–5.78 (m, 1H), 5.32–5.36 (m, 1H), 4.79 (dd, J=
7.7, 5.3 Hz, 1H), 4.50 (d, J=7.7 Hz, 1H), 4.26–4.30 (m, 1H), 4.01 (dq, J=
9.6, 7.1 Hz, 1H), 3.80 (s, 3H), 3.59 (dq, J=9.6, 7.1 Hz, 1H), 3.18 (brs,
1H), 2.19–2.23 (m, 2H), 1.23 ppm (t, J=7.1 Hz, 3H); 13C NMR
(125 MHz, CDCl3): d=159.4, 131.9, 128.5, 125.4, 124.7, 113.7, 98.5, 78.8,
76.4, 64.5, 55.2, 31.1, 15.2 ppm; HRMS (EI) m/z: calcd for C15H20O4:
264.1362; found: 264.1367.
(1R)-2-{[tert-Butyl(dimethyl)silyl]oxy}-1-[(2R,6S)-6-ethoxy-5,6-dihydro-
2H-pyran-2-yl]ethanol (4i): Same procedure as for 4a except that the al-
lylboration was carried out with tert-butyl(dimethylsilyloxy)acetaldehyde
(697 mg, 4.00 mmol). Purification by flash-column chromatography (de-
activated silica-gel, hexane/ether 9:1) led to the pure product 4i (496 mg,
82%) as clear oil. [a]2D3 =+34.5 (c=1.0 in CHCl3); IR (CH2Cl2, cast): n˜ =
(R)-[(2R,6S)-6-Ethoxy-5,6-dihydro-2H-pyran-2-yl](4-chlorophenyl)me-
thanol (4d): Same procedure as for 4a, except that the allylboration with
4-chlorobenzaldehyde (280 mg, 2.00 mmol) took place at 408C for 24 h.
Purification by flash-column chromatography (deactivated silica-gel,
hexane/ether 9:1) led to the pure product 4d (206 mg, 77%) as a clear
3324, 3038, 2857, 1317 cmÀ1 1H NMR (300 MHz, CDCl3): d=5.78–5.86
;
oil. [a]2D3 =+48.4 (c=1.0 in CHCl3); H NMR (300 MHz, CDCl3): d=7.34
1
(m, 1H), 5.66–5.70 (m, 1H), 4.76 (dd, J=6.2, 4.7 Hz, 1H), 4.41–4.45 (m,
1H), 3.93 (dq, J=9.6, 7.1 Hz, 1H), 3.60–3.76 (m, 3H), 3.50 (dq, J=9.6,
7.1 Hz, 1H), 2.62 (d, J=5.9 Hz, 1H), 2.18–2.22 (m, 2H), 1.25 (t, J=
7.1 Hz, 3H), 0.86 (s, 9H), 0.02ppm (s, 6H); 13C NMR (125 MHz,
CDCl3): d=126.8, 124.5, 98.4, 73.9, 73.2, 64.4, 63.2, 31.0, 25.9, 18.2, 15.1,
À5.4, À5.5 ppm; HRMS (ESI): m/z: calcd for C15H30O4NaSi: 325.1806;
found: 325.1804.
(s, 4H), 5.78–5.82(m, 1H), 5.40 (dd, J=10.3, 1.8 Hz, 1H), 4.79 (t, J=
5.5 Hz, 1H), 4.61 (d, J=7.0 Hz, 1H), 4.24–4.33 (m, 1H), 3.98 (dq, J=9.6,
7.1 Hz, 1H), 3.58 (dq, J=9.6, 7.1 Hz, 1H), 3.30 (brs, 1H), 2.20–2.27 (m,
2H), 1.26 ppm (t, J=7.1 Hz, 3H); 13C NMR (50 MHz, CDCl3): d=138.6,
133.7, 128.6, 128.5, 125.2, 125.1, 98.4, 78.4, 76.0, 64.5, 30.9; 15.2 ppm; ele-
mental analysis calcd for C14H17ClO3: C 62.57, H 6.38; found: C 62.76, H
6.81.
(1R)-1-[(2R,6S)-6-Ethoxy-5,6-dihydro-2H-pyran-2-yl]undecan-1-ol (4j):
Same procedure as for 4a except that the allylboration was carried out
with undecanal (680 mg, 4.00 mmol). Purification by flash-column chro-
matography (deactivated silica-gel, hexane/ether 9:1) led to the pure
product 4j (530 mg, 89%) as a clear oil. [a]2D3 =+54.7 (c=1.0 in CHCl3);
(R)-[(2R,6S)-6-Ethoxy-5,6-dihydro-2H-pyran-2-yl](4-fluorophenyl)me-
thanol (4e): Same procedure as for 4a, except that the allylboration with
4-fluorobenzaldehyde (248 mg, 2.00 mmol) took place at 408C for 24 h.
Purification by flash-column chromatography (deactivated silica-gel,
hexane/ether 9:1) led to the pure product 4e (189 mg, 75%) as a solid.
IR (CH2Cl2, cast): n˜ =3454, 3040, 2854, 1209 cmÀ1 1H NMR (300 MHz,
;
1
M.p. 698C; [a]2D3 =+13.7 (c=1.0 in CHCl3); H NMR (300 MHz, CDCl3):
CDCl3): d=5.80–5.86 (m, 1H), 5.62–5.68 (m, 1H), 4.76 (dd, J=5.5,
5.5 Hz, 1H), 4.12–4.16 (m, 1H), 3.96 (dq, J=9.5, 7.1 Hz, 1H), 3.46–3.62
(m, 2H), 2.42 (d, J=5.7 Hz, 1H), 2.19–2.23 (m, 2H), 1.20–1.60 (m, 21H),
0.88 ppm (t, J=6.8 Hz, 3H); 13C NMR (125 MHz, CDCl3): d=126.7,
124.7, 98.5, 77.2, 73.3, 64.3, 33.0, 31.9, 31.1 29.7, 29.6, 29.6, 29.5, 29.3, 25.6,
22.6, 15.1, 14.0 ppm; HRMS (EI): m/z: calcd for C18H34O3: 298.2508;
found: 298.2504.
d=7.32–7.49 (m, 2H), 7.01–7.22 (m, 2H), 5.72–5.87 (m, 1H), 5.33–5.47
(m, 1H), 4.83 (t, J=5.4 Hz, 1H), 4.65 (dd, J=7.3, 2.2 Hz, 1H), 4.27–4.39
(m, 1H), 4.06 (dq, J=9.5, 7.1 Hz, 1H), 3.67 (dq, J=9.5, 7.1 Hz, 1H), 3.43
(brs, 1H), 2.22–2.32 (m, 2H), 1.30 ppm (t, J=7.1 Hz, 3H); 13C NMR
(50 MHz, CDCl3): d=162.4 (J(C,F)=4.8 Hz), 135.8 (J(C,F)=0.1 Hz),
135.7, 129.0, 128.9, 125.2, 125.1, 115.4, 115.0, 98.5, 78.7, 76.2, 64.6, 31.0;
15.2; elemental analysis calcd for C14H17FO3: C 68.16, H 7.63; found: C
68.16, H 7.81.
Solvent-free procedure for the preparation of 4k and 4m–4p: The cyclo-
addition reaction was carried out by using the same procedure as that for
4a. After the completion of the cycloaddition reaction, the ethyl vinyl
ether was evaporated in vacuo and the aldehyde (4.00 mmol) was added
to the residue. The reaction was stirred at ambient or an elevated temper-
ature for 18–48 h, then diluted with EtOAc and filtered through celite.
The EtOAc solution was stirred for 30 min with an aqueous saturated so-
lution of NaHCO3. The organic layer was separated and the aqueous
layer was extracted with EtOAc (220 mL). The combined organic
layers were washed with an aqueous saturated solution of NaCl then
dried over anhydrous MgSO4, filtered, and concentrated to afford 4k or
4m–4p as a crude product. Purification by flash-column chromatography
(deactivated silica-gel, hexanes/ether) led to the pure product 4k or prod-
ucts 4m–4p.
(1R)-1-[(2R,6S)-6-Ethoxy-5,6-dihydro-2H-pyran-2-yl]-2-phenylethanol
(4 f): Same procedure as for 4a, except that the allylboration with phe-
nylacetaldehyde (240 mg, 2.00 mmol) took place at 458C for 24 h. Purifi-
cation by flash-column chromatography (deactivated silica-gel, hexane/
ether 9:1) led to the pure product 4 f (204 mg, 82%) as a clear oil. [a]D23
=
+23.7 (c=1.0 in CHCl3); 1H NMR (300 MHz, CDCl3) d=7.25–7.50 (m,
5H), 5.82–5.94 (m, 1H), 5.62–5.70 (m, 1H), 4.80 (t, J=5.4 Hz, 1H), 4.13–
4.21 (m, 1H), 4.09 (dq, J=9.5, 7.1 Hz, 1H), 3.72–3.89 (m, 1H), 3.66 (dq,
J=9.5, 7.1 Hz, 1H), 3.02(d, J=13.5, 6.9 Hz, 1H), 2.92 (d, J=12.5,
7.1 Hz, 1H,), 2.60 (brs, 1H), 2.22–2.29 (m, 2H), 1.25 ppm (t, J=7.1 Hz,
3H); 13C NMR (50 MHz, CDCl3): d=138.9, 129.8, 128.9, 127.3, 126.8,
125.4, 98.9, 75.7, 74.7, 64.9, 40.0, 31.4, 15.7 ppm; HRMS (EI): m/z: calcd
for C13H14O2: 202.0994 [MÀHOC2H5]+; found: 202.0990.
(1R)-1-[(2R,6S)-6-Ethoxy-5,6-dihydro-2H-pyran-2-yl]-2-methylpropan-1-
ol (4k): Colorless oil; Yield: 270 mg, 78%; [a]2D3 =À71.0 (c=1.6 in
(1R)-1-[(2R,6S)-6-Ethoxy-5,6-dihydro-2H-pyran-2-yl]-3-phenylpropan-1-
ol (4g): Same procedure as for 4a, except that the allylboration with hy-
drocinnamaldehyde (264 mg, 2.00 mmol) took place at 458C for 24 h. Pu-
rification by flash-column chromatography (deactivated silica-gel,
hexane/ether 9:1) led to the pure product 4g (193 mg, 74%) as a clear
oil. [a]2D3 =+70.7 (c=1.0 in CHCl3); 1H NMR (300 MHz, CDCl3): d=
7.16–7.34 (m, 5H), 5.80–5.89 (m, 1H), 5.64 (dq, J=10.3, 1.7 Hz, 1H),
4.76 (dd, J=5.4, 6.0 Hz, 1H), 4.15–4.22 (m, 1H), 3.98 (dq, J=9.5, 7.1 Hz,
1H), 3.53–3.65 (m, 2H), 2.84–2.96 (m, 1H), 2.68–2.81 (m, 1H), 2.58 (brd,
J=5.8 Hz, 1H), 2.20–2.28 (m, 2H), 1.82–2.02 (m, 2H), 1.30 ppm (t, J=
7.1 Hz, 3H); 13C NMR (50 MHz, CDCl3): d=142.2, 128.5, 128.4, 126.5,
125.8, 124.9, 98.5, 77.3, 72.6, 64.4, 35.0, 32.0, 31.0, 15.2 ppm; HRMS (EI):
m/z: calcd for C14H16O2: 216.1150 [MÀHOC2H5]+; found: 216.1150.
CHCl3); IR (CH2Cl2, cast): n˜ =3454, 3039, 1471, 1237 cmÀ1 1H NMR
;
(300 MHz, CDCl3): d=5.79–5.86 (m, 1H), 5.61–5.66 (m, 1H), 4.75 (dd,
J=6.0, 5.0 Hz, 1H), 4.32–4.37 (m, 1H), 3.96 (dq, J=9.6, 7.1 Hz, 1H),
3.58 (dq, J=9.6, 7.1 Hz, 1H), 3.21 (ddd, J=7.0, 7.0, 3.9 Hz, 1H), 2.32 (d,
J=7.2 Hz, 1H), 2.19–2.25 (m, 2H), 1.91 (octet, J=6.8 Hz, 1H), 1.62–1.66
(m, 6H), 1.25 (t, J=7.1 Hz, 3H), 1.02(d, J=6.8 Hz, 3H), 0.98 ppm (d,
J=6.8 Hz, 3H); 13C NMR (125 MHz, CDCl3): d=127.4, 124.6, 98.4, 78.1,
75.0, 64.3, 30.9, 30.6, 19.5, 18.1, 15.1 ppm; HRMS (ESI): m/z: calcd for
C11H20O3Na: 223.1305; found: 223.1303.
(1R,2E)-1-[(2R,6S)-6-Ethoxy-5,6-dihydro-2H-pyran-2-yl]-2-methylbut-2-
en-1-ol (4m): Colorless oil; Yield: 323 mg, 76%; [a]2D3 =+57.1 (c=1.0 in
CHCl3); IR (CH2Cl2, cast): n˜ =3462, 3041, 1650, 1256 cmÀ1 1H NMR
;
(1R)-1-[(2R,6S)-6-Ethoxy-5,6-dihydro-2H-pyran-2-yl]-3-methylbutan-1-ol
(4h): Same procedure as for 4a except that the allylboration was carried
out with isovaleraldehyde (344 mg, 4.00 mmol). Purification by flash-
column chromatography (deactivated silica-gel, hexane/ether 9:1) led to
the pure product 4h (347 mg, 81%) as a clear oil. [a]2D3 =+98.0 (c=1.0 in
(300 MHz, CDCl3): d=5.76–5.82(m, 1H), 5.46–5.62(m, 2H), 4.78 (dd,
J=6.2, 5.0 Hz, 1H), 4.22–4.28 (m, 1H), 3.86–4.02 (m, 2H), 3.58 (dq, J=
9.6, 7.1 Hz, 1H), 2.80 (brs, 1H), 2.19–2.23 (m, 2H), 1.62–1.66 (m, 6H),
1.23 ppm (t, J=7.1 Hz, 3H); 13C NMR (125 MHz, CDCl3): d=133.8,
126.0, 124.4, 124.2, 98.6, 79.9, 76.0, 63.4, 31.1, 15.2, 13.1, 11.6 ppm; HRMS
(ESI): m/z: calcd for C12H20O3Na: 235.1305; found: 235.1299.
CHCl3); IR (CH2Cl2, cast): n˜ =3446, 3041, 1467, 1293 cmÀ1
(300 MHz, CDCl3): d=5.79–6.05 (m, 1H), 5.62–5.68 (m, 1H), 4.73 (dd,
;
1H NMR
Chem. Eur. J. 2006, 12, 3132– 3142
ꢁ 2006 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
3139